OncoMedX – Oncology Pharmaceutical Consult… SRL
OncoMedX – Oncology Pharmaceutical Consult… reported total assets of 6,701 € at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Aug 2026).
The score of OncoMedX – Oncology Pharmaceutical Consult… shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -74 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
OncoMedX – Oncology Pharmaceutical Consult…'s annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
OncoMedX – Oncology Pharmaceutical Consult…'s financial analysis
- Solvency-345.8%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of OncoMedX – Oncology Pharmaceutical Consult…
1 active director(s) in the register.
OncoMedX – Oncology Pharmaceutical Consult…'s shareholders and holdings →OncoMedX – Oncology Pharmaceutical Consult…'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0738.436.452
- VAT number
- BE0738436452
- Peppol
- Registered · 0208:0738436452 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Nov 2019
- Registered office
- 1750 Lennik
- Latest accounts
- 2025 · filed on 26 Aug 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
OncoMedX – Oncology Pharmaceutical Consult… (SRL) has been based in Lennik since 2019, active in: business and other management consultancy activities. For 2025, it reports a net loss of 96 € and equity of −23,172 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to OncoMedX – Oncology Pharmaceutical Consult…
Companies in the same business, of comparable size and area, outside its group.
- Katharina Klapper Consulting Business and other management consultancy activities Uccle · balance sheet 6,595 €
- Strole and Co Business and other management consultancy activities Uccle · balance sheet 6,899 €
- ReynkensConsult Business and other management consultancy activities Heusden-Zolder · balance sheet 6,387 €
- Amjoma Business and other management consultancy activities Roeselare · balance sheet 6,201 €
- Dirkx Consult Business and other management consultancy activities Hasselt · balance sheet 6,183 €
- Inquinox Business and other management consultancy activities Glabbeek · balance sheet 7,332 €
- Nagenius Business and other management consultancy activities Nivelles · balance sheet 6,084 €
- Barmaz Business and other management consultancy activities Genk · balance sheet 6,065 €
Frequently asked questions about OncoMedX – Oncology Pharmaceutical Consult…
What is the revenue of OncoMedX – Oncology Pharmaceutical Consult…?
OncoMedX – Oncology Pharmaceutical Consult… files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of OncoMedX – Oncology Pharmaceutical Consult…?
In Belgium, the VAT number is the company number prefixed with BE: BE0738436452 for OncoMedX – Oncology Pharmaceutical Consult…, if the company is VAT-registered. Its company number (CBE) is 0738.436.452.
Where is the registered office of OncoMedX – Oncology Pharmaceutical Consult…?
According to the CBE register, the registered office of OncoMedX – Oncology Pharmaceutical Consult… is in 1750 Lennik.
What is the equity of OncoMedX – Oncology Pharmaceutical Consult…?
At the close of the 2025 financial year, the equity of OncoMedX – Oncology Pharmaceutical Consult… amounts to -23,172 €, a solvency of -345.8% of total assets.
Who manages OncoMedX – Oncology Pharmaceutical Consult…?
The register lists 1 active mandates at OncoMedX – Oncology Pharmaceutical Consult…. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of OncoMedX – Oncology Pharmaceutical Consult…
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →